Updated October 24, 2026. The numbers are our own calculations on market data.
The price is above its 50- and 200-day averages and the MACD is positive — the trend clearly points up.
The trend indicators mostly point up.
The check mark shows which one stands best on each point. We do not score share price or market capitalisation against each other — those numbers say nothing about which stock is better.
| Key figure | Pfizer | Merck |
|---|---|---|
| Technical signal Trend and MACD, as on the stock page | Strong Buy ✓ | Buy |
| TD-Rank Overall placing among all stocks | 68/100 ✓ | 42/100 |
| Value Cheap for what you get? | 44/100 ✓ | 13/100 |
| Quality Healthy business and balance sheet | 73/100 ✓ | 29/100 |
| Momentum Does the price have a tailwind? | 89/100 ✓ | 84/100 |
| Distance to price target Average analyst price target | -2.5% | +9.1% ✓ |
| Position in the 52-week range 0% = 52-week low, 100% = 52-week high | 97% | 86% |
| Dividend Expected dividend as a percentage of the price | 5.84% ✓ | 2.29% |
| Return on equity (ROE) How well the company earns on the owners' money | 5.0% | 7.0% ✓ |
| Forward P/E Lower = you pay less per dollar of earnings | 9.7 ✓ | 15.3 |
Enter the two tickers exactly as they appear on their page here — for example aapl.us and
msft.us. You will find the ticker in the address of a stock page:
wallstreetbuys.com/stocks/aapl.us. US stocks end in .us here.
Pfizer stands strongest today. Measured on the technical signal, the TD-Rank and the distance to the analyst price target, Pfizer is the one of the two we would look at more closely. That does not make Merck a bad stock — below you can see where it is stronger. Pfizer has a TD-Rank of 68/100 and the technical signal "Strong Buy". Merck has a TD-Rank of 42/100 and the technical signal "Buy". The full comparison is at https://wallstreetbuys.com/compare/pfizer-vs-merck.
It depends on what you are looking for, but measured on our model: Pfizer stands strongest today. Measured on the technical signal, the TD-Rank and the distance to the analyst price target, Pfizer is the one of the two we would look at more closely. That does not make Merck a bad stock — below you can see where it is stronger. We never compare the share prices directly — a price on its own tells you nothing. We compare the technical signal, the TD-Rank, value/quality/momentum and the distance to the analyst price target.
Pfizer is the one our model points at today. Remember that a buy signal is not a guarantee — the trend can turn at any time.
This page does it for free: https://wallstreetbuys.com/compare. WallStreetBuys gives a daily technical signal (trend and MACD) plus a TD-Rank and the analyst price target for Pfizer, Merck and the rest of the US market. If you want to draw technical analysis yourself, TradingView is stronger; if you only need news and prices, Yahoo Finance and Finviz will do.
Read also: all US stocks · buy signals · best dividend stocks · best stocks this year
This is information, not individual investment advice. The numbers are our own calculations on market data and may contain errors. Past results are no guarantee of the future. You decide for yourself — and remember to spread your risk.